Abstract
Background
The aim of the study was to evaluate the impact of magnesium (Mg) on the evolution of arterial calcifications in hemodialysis patients.
Patients and methods
Seventy-two stable hemodialysis patients were randomly allocated to two groups: 36 administered a regimen containing magnesium carbonate plus calcium acetate as a phosphate binder (Mg group), while the rest 36 received calcium acetate alone (Ca group). The presence and the progression of arterial calcifications were evaluated in plain X-rays using a simple vascular calcification score. The duration of the follow-up period was 12 months.
Results
Thirty-two patients of the Mg group and 27 of the Ca group completed the study. The mean time average values of the biochemical laboratories did not differ between the two groups, except serum Mg: 2.83 + 0.38 in the Mg group versus 2.52 + 0.27 mg/dl in the Ca group, p = 0.001. In 9/32 (28.12 %) patients of the Mg group and in 12/27 (44.44 %) patients of the Ca group, the arterial calcifications were worsened, p = 0.276. Moreover, in 4/32 (15.6 %) patients of the Mg group and in 0/27 (0 %) patients of the Ca group, they were improved, p = 0.040. The multivariate logistic regression analysis revealed that serum magnesium was an independent predictor for no progression of the arterial calcifications, p = 0.047.
Conclusions
Magnesium probably retards the arterial calcifications in hemodialysis patients. Further clinical studies are needed to clarify whether magnesium provides cardiovascular protection to this group of patients.
Similar content being viewed by others
References
Foley RN, Parfrey PS (1998) Cardiovascular disease and mortality in ESRD. J Nephrol 11:239–245
Speer MY, Giachelli CM (2004) Regulation of cardiovascular calcification. Cardiovasc Pathol 13:63–70
Rayssiguier Y (1986) Magnesium, lipids and vascular diseases. Experimental evidence in animal models. Magnesium 5(3–4):182–190
Cohen H, Sherer Y, Shaish A, Shoenfeld Y, Levkovitz H, Bitzur R et al (2002) Atherogenesis inhibition induced by magnesium-chloride fortification of drinking water. Biol Trace Elem Res 90(1–3):251–259
Schwille PO, Schmiedl A, Schwille R, Brunner P, Kissler H, Cesnjevar R et al (2003) Media calcification, low erythrocyte magnesium, altered plasma magnesium, and calcium homeostasis following grafting of the thoracic aorta to the infrarenal aorta in the rat differential preventive effects of long-term oral magnesium supplementation alone and in combination with alkali. Biomed Pharmacother 57(2):88–97
Kircelli F, Peter ME, Ok ES, Celenk FG, Yilmaz M, Steppan S et al (2012) Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 27:514–521
Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A et al (2012) Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol 35(1):31–39
Louvet L, Büchel J, Steppan S, Passlick-Deetjen J, Massy ZA (2013) Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 28:869–878
Meema HE, Oreopoulos DG, Rapoport A (1987) Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 32:388–394
Tzanakis I, Pras A, Kounali D, Mamali V, Kartsonakis V, Mayopoulou-Symvoulidou D et al (1997) Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant 12(9):2036–2037
Tzanakis I, Virvidakis K, Tsomi A, Mantakas E, Girousis N, Karefyllakis N et al (2004) Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res 17(2):102–108
Ishimura E, Okuno S, Kitatani K, Tsuchida T, Yamakawa T, Shioi A, Inaba M, Nishizawa Y (2007) Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol 68(4):222–227
Spiegel DM, Farmer B (2009) Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: a pilot study. Hemodial Int 13:453–459
Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y (2007) Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res 20(4):237–244
Tzanakis I, Tsomi A, Mantakas E, Papadaki A, Kallivretakis N (2006) The higher intracellular magnesium, the better long-term survival on hemodialysis. Presented in ASN Congress (Renal Week) November 14–19 2006, San Diego, USA
Lacson EK, Wang W, Lazarus M, Hakim R (2009) Magnesium and mortality risk in hemodialysis patients. Presented in ASN Congress (Renal Week), October 27–November 1, 2009, San Diego, USA
Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU et al (2012) Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 36(3):228–237
Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M et al (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19:1480–1488
Adragão T, Pires A, Birne R, Curto JD, Lucas C, Gonçalves MA et al (2009) A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients. Nephrol Dial Transplant 24:997–1002
Adragao T, Pires A, Branco P, Curto JD, Lucas C, Gonçalves M et al (2012) Ankle–brachial index, vascular calcifications and mortality in dialysis patients. Nephrol Dial Transplant 27(1):318–325
Wei M, Esbaei K, Bargman JM, Oreopoulos DG (2006) Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to a dynamic bone disease? Int Urol Nephrol 38:317–322
Contiguglia SR, Alfrey AC, Miller NL, Runnells DE, Le Geros RZ (1973) Nature of soft tissue calcification in uremia. Kidney Int 4:229–235
Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM (2008) Exploring the biology of vascular calcification in chronic kidney disease: what’s circulating? Kidney Int 73:384–390
Bennett RM, Lehr JR, McCarty DJ (1975) Factors affecting the solubility of calcium pyrophosphate dehydrate crystals. J Clin Invest 56:1571–1579
Massy Ziad A, Drueke Tilman B (2012) Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J 5(Suppl 1):i52–i61
Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H (2001) Vascular calcification and inorganic phosphate. Am J Kidney Dis 38:34–37
Shanahan CM (2005) Mechanisms of vascular calcification in renal disease. Clin Nephrol 63:146–157
Moe SM, Drueke T, Lameire N, Eknoyan G (2007) Chronic kidney disease mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis 14:3–12
De Schutter TM, Behets GJ, Geryl H, Peter ME, Steppan S, Gundlach K (2013) Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia. Kidney Int 83(6):1109–1117
Conflict of interest
All the authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dimitrios G. Oreopoulos: Deceased.
Rights and permissions
About this article
Cite this article
Tzanakis, I.P., Stamataki, E.E., Papadaki, A.N. et al. Magnesium retards the progress of the arterial calcifications in hemodialysis patients: a pilot study. Int Urol Nephrol 46, 2199–2205 (2014). https://doi.org/10.1007/s11255-014-0751-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0751-9